Benefit-risk assessment of acne therapies [12]

Lancet

Volumn 349, Issue 9060, 1997, Pages 1251-1252

  Seukeran, D C ^a   Eady, E A ^a   Cunliffe, W J ^a   Beneton, N ^a   Bocquet, H ^a   Cosnes, A ^a   Revuz, J ^a   Roujeau, J C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; MINOCYCLINE; OXYTETRACYCLINE; TETRACYCLINE;

ACNE; DRUG HYPERSENSITIVITY; HUMAN; LETTER; LIVER FUNCTION; LIVER TOXICITY; NEGRO; PATIENT MONITORING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK BENEFIT ANALYSIS;

EID: 0030890560     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62445-2     Document Type: Letter

References (0)